FDA commissioner Marty Makary said it would be “magical” for consumers to see prescription drugs on pharmacy shelves instead ...
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
GlobalData on MSN
FDA prevails over EMA in 2025 novel drug approvals
This is eight fewer than the FDA, which approved 46 novel drugs in 2025 – sneaking in two regulatory decisions during the ...
3don MSN
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
2don MSN
Legal questions swirl around FDA’s new expedited drug program, including who should sign off
FDA staffers and outside experts worry the program runs afoul of legal, ethical and scientific standards used to review new ...
For years, the federal government advised Americans to limit red meat and foods high in saturated fats. However, new federal ...
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...
More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...
In early 2025, the FDA was rocked by sweeping layoffs and leadership turnover, raising questions about whether the agency ...
It means there is a risk of 'serious adverse health consequences or death' if the product is consumed by certain people.
The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results